Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11186650 Anti-CD3 antibodies and methods of use

Patent 11186650 was granted and assigned to Genentech on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11186650

Patent Inventor Names

Xiaocheng Chen0

Mark S. Dennis0

Mary A. Mathieu0

Robert F. Kelley0

Allen J. Ebens, Jr.0

Liping L. Sun0

Date of Patent

November 30, 2021

Patent Application Number

16144686

Date Filed

September 27, 2018

Patent Primary Examiner

‌

Zachary S Skelding

Patent abstract

The invention provides anti-cluster of differentiation 3 (CD3) antibodies and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11186650 Anti-CD3 antibodies and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API